Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Integrative Methods Address Common Breast Cancer Quality-of-Life Issues

June 28th 2024, 7:00pm

Article

At the CURE® Educated Patient® Breast Cancer Summit, an expert discussed integrative methods that can improve quality of life.

Biomarker Testing Is Essential in HR-Positive Metastatic Breast Cancer

June 27th 2024, 3:00pm

Article

Patients with HR-positive metastatic breast cancer can expect to undergo biomarker testing both at diagnosis and again if the disease progresses.

Having a Cancer Community on Social Media Can Be Healing

June 26th 2024, 7:01pm

Video

Talking about the good, bad and ugly aspects of cancer on social media is “the most healing part of this community,” a survivor said.

Side Effects to Monitor During HER2-Positive Breast Cancer Treatment

June 26th 2024, 3:00pm

Article

One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

When Art Captures the Cancer Experience

June 18th 2024, 5:04pm

Article

Having my metastatic breast cancer experience turned into a piece of art was such a meaningful opportunity.

Sharing Breast Cancer Experiences is the ‘Most Special Thing’

June 12th 2024, 3:10pm

Article

Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.

Enhertu Boosts PFS in Pretreated, HR-Positive, HER2-Low and -Ultralow Breast Cancer

June 2nd 2024, 7:00pm

Article

Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.

FDA to Review Inavolisib Combo for HR-Positive, HER2-Negative Breast Cancer

May 22nd 2024, 7:00pm

Article

The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.

A Life Too Soon Taken by Metastatic Breast Cancer

May 21st 2024, 5:00pm

Article

When I received news of a fellow blogger’s demise, I was heartbroken.

Palliative Care: The Superheroes of Oncology

May 11th 2024, 5:00pm

Article

After seeing how palliative care helped me through cancer, I now advocate for these services to other patients.